Kardigan, Inc. Common Stock Total Assets
Kardigan, Inc. Common Stock total assets. Based on the latest financial reports, Kardigan, Inc. Common Stock (KARD) holds total assets worth $721.79 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Kardigan, Inc. Common Stock for the company's overall valuation and market capitalisation.
Total Assets of Kardigan, Inc. Common Stock (2024–2025)
Total assets of Kardigan, Inc. Common Stock from 2024 to 2025. This chart illustrates how Kardigan, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See KARD stock price and chart for real-time trading data and today's change.
Kardigan, Inc. Common Stock - Asset Composition Analysis
Kardigan, Inc. Common Stock Total Assets Breakdown (December 2025)
Kardigan, Inc. Common Stock total assets breakdown as of December 2025. Kardigan, Inc. Common Stock's total assets of $721.79 Million consist of 88.3% current assets and 11.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 27.9% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $23.23 Million | 5.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2024–2025)
This chart illustrates how Kardigan, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Kardigan, Inc. Common Stock short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kardigan, Inc. Common Stock's current assets represent 88.3% of total assets in 2025, an increase from 79.2% in 2024.
- Cash Position: Cash and equivalents constituted 27.9% of total assets in 2025, down from 77.8% in 2024.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2024.
- Asset Diversification: The largest asset category is intangible assets at 5.9% of total assets.
Kardigan, Inc. Common Stock Competitors by Total Assets
Key competitors of Kardigan, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
HLB Co. Ltd
KQ:028300
|
Korea | ₩925.44 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Shanghai Medicilon Inc
SHG:688202
|
China | CN¥2.88 Billion |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
India | Rs16.41 Billion |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767
|
China | CN¥2.49 Billion |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
|
China | CN¥725.73 Million |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
|
China | CN¥3.67 Billion |
Kardigan, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.72 | 9.42 | - |
| Quick Ratio | 8.72 | 9.42 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | $540.16 Million | $266.47 Million | - |
Kardigan, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Kardigan, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.28 |
| Latest Market Cap to Assets Ratio | 3.38 |
| Asset Growth Rate (YoY) | 515.4% |
| Total Assets | $390.94 Million |
| Market Capitalization | $1.32 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Kardigan, Inc. Common Stock's assets at a significant premium (3.38x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Kardigan, Inc. Common Stock's assets grew by 515.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kardigan, Inc. Common Stock (2024–2025)
The table below shows the annual total assets of Kardigan, Inc. Common Stock from 2024 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $390.94 Million | +515.40% |
| 2024-12-31 | $63.53 Million | -- |
About Kardigan, Inc. Common Stock
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI… Read more